GABELLI FUNDS LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$7,000
+40.0%
10,4110.0%0.00%
Q3 2020$5,000
-66.7%
10,411
-49.0%
0.00%
Q2 2020$15,000
+50.0%
20,411
+96.1%
0.00%
Q1 2020$10,000
-52.4%
10,4110.0%0.00%
Q4 2019$21,000
-30.0%
10,4110.0%0.00%
Q3 2019$30,000
-62.5%
10,4110.0%0.00%
-100.0%
Q2 2019$80,00010,4110.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders